Human medicines European public assessment report (EPAR): Orencia, abatacept, Arthritis, Psoriatic,Arthritis, Juvenile Rheumatoid,Arthritis, Rheumatoid, Date of authorisation: 21/05/2007, Revision: 27, Status: Authorised

Case Medical Research ◽

10.31525/cmr-eceeaf ◽

2019 ◽

Author(s):

Keyword(s):

Rheumatoid Arthritis ◽

Psoriatic Arthritis ◽

Juvenile Rheumatoid Arthritis ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Arthritis Rheumatoid

Download Full-text

Human medicines European public assessment report (EPAR): Orencia, abatacept, Arthritis, Psoriatic,Arthritis, Juvenile Rheumatoid,Arthritis, Rheumatoid, Date of authorisation: 21/05/2007, Revision: 30, Status: Authorised

Case Medical Research ◽

10.31525/cmr-ed3b54 ◽

2019 ◽

Author(s):

Keyword(s):

Rheumatoid Arthritis ◽

Psoriatic Arthritis ◽

Juvenile Rheumatoid Arthritis ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Arthritis Rheumatoid

Download Full-text

Human medicines European public assessment report (EPAR): Erelzi, etanercept, Arthritis, Psoriatic,Psoriasis,Arthritis, Juvenile Rheumatoid,Arthritis, Rheumatoid,Spondylitis, Ankylosing, Date of authorisation: 23/06/2017, Revision: 4, Status: Authorised

Case Medical Research ◽

10.31525/cmr-2115716 ◽

2019 ◽

Author(s):

Keyword(s):

Rheumatoid Arthritis ◽

Juvenile Rheumatoid Arthritis ◽

Assessment Report ◽

Psoriasis Arthritis ◽

European Public ◽

European Public Assessment Report ◽

Spondylitis Ankylosing ◽

Arthritis Rheumatoid

Download Full-text

Human medicines European public assessment report (EPAR): Erelzi, etanercept, Arthritis, Psoriatic,Psoriasis,Arthritis, Juvenile Rheumatoid,Arthritis, Rheumatoid,Spondylitis, Ankylosing, Date of authorisation: 23/06/2017, Revision: 4, Status: Authorised

Case Medical Research ◽

10.31525/cmr-208eb0e ◽

2019 ◽

Author(s):

Keyword(s):

Rheumatoid Arthritis ◽

Juvenile Rheumatoid Arthritis ◽

Assessment Report ◽

Psoriasis Arthritis ◽

European Public ◽

European Public Assessment Report ◽

Spondylitis Ankylosing ◽

Arthritis Rheumatoid

Download Full-text

Human medicines European public assessment report (EPAR): Nordimet, methotrexate, Arthritis, Psoriatic,Psoriasis,Arthritis, Juvenile Rheumatoid,Arthritis, Rheumatoid, Date of authorisation: 18/08/2016, Revision: 8, Status: Authorised

Case Medical Research ◽

10.31525/cmr-d7cc27 ◽

2019 ◽

Author(s):

Keyword(s):

Rheumatoid Arthritis ◽

Juvenile Rheumatoid Arthritis ◽

Assessment Report ◽

Psoriasis Arthritis ◽

European Public ◽

European Public Assessment Report ◽

Arthritis Rheumatoid

Download Full-text

Human medicines European public assessment report (EPAR): Nordimet, methotrexate, Arthritis, Psoriatic,Psoriasis,Arthritis, Juvenile Rheumatoid,Arthritis, Rheumatoid, Date of authorisation: 18/08/2016, Revision: 6, Status: Authorised

Case Medical Research ◽

10.31525/cmr-d8201f ◽

2019 ◽

Author(s):

Keyword(s):

Rheumatoid Arthritis ◽

Juvenile Rheumatoid Arthritis ◽

Assessment Report ◽

Psoriasis Arthritis ◽

European Public ◽

European Public Assessment Report ◽

Arthritis Rheumatoid

Download Full-text

Human medicines European public assessment report (EPAR): Enbrel, etanercept, Spondylitis, Ankylosing,Arthritis, Juvenile Rheumatoid,Arthritis, Psoriatic,Psoriasis,Arthritis, Rheumatoid, Date of authorisation: 02/02/2000, Revision: 59, Status: Authorised

Case Medical Research ◽

10.31525/cmr-59961a ◽

2019 ◽

Author(s):

Keyword(s):

Rheumatoid Arthritis ◽

Juvenile Rheumatoid Arthritis ◽

Assessment Report ◽

Psoriasis Arthritis ◽

European Public ◽

European Public Assessment Report ◽

Spondylitis Ankylosing ◽

Arthritis Rheumatoid

Download Full-text

Human medicines European public assessment report (EPAR): Enbrel, etanercept, Spondylitis, Ankylosing,Arthritis, Juvenile Rheumatoid,Arthritis, Psoriatic,Psoriasis,Arthritis, Rheumatoid, Date of authorisation: 02/02/2000, Revision: 58, Status: Authorised

Case Medical Research ◽

10.31525/cmr-5970b9 ◽

2019 ◽

Author(s):

Keyword(s):

Rheumatoid Arthritis ◽

Juvenile Rheumatoid Arthritis ◽

Assessment Report ◽

Psoriasis Arthritis ◽

European Public ◽

European Public Assessment Report ◽

Spondylitis Ankylosing ◽

Arthritis Rheumatoid

Download Full-text

Human medicines European public assessment report (EPAR): Idacio, adalimumab, Arthritis, Rheumatoid,Arthritis, Juvenile Rheumatoid,Psoriasis,Arthritis, Psoriatic,Spondylitis, Ankylosing,Uveitis,Hidradenitis Suppurativa,Colitis, Ulcerative,Crohn Disease, Date of authorisation: 02/04/2019, Status: Authorised

Case Medical Research ◽

10.31525/cmr-105efa3 ◽

2019 ◽

Author(s):

Keyword(s):

Rheumatoid Arthritis ◽

Crohn Disease ◽

Hidradenitis Suppurativa ◽

Assessment Report ◽

Psoriasis Arthritis ◽

European Public ◽

European Public Assessment Report ◽

Colitis Ulcerative ◽

Spondylitis Ankylosing ◽

Arthritis Rheumatoid

Download Full-text

Human medicines European public assessment report (EPAR): Jylamvo, methotrexate, Arthritis, Psoriatic,Precursor Cell Lymphoblastic Leukemia-Lymphoma,Psoriasis,Arthritis, Rheumatoid,Arthritis, Date of authorisation: 29/03/2017, Revision: 4, Status: Authorised

Case Medical Research ◽

10.31525/cmr-f38737 ◽

2019 ◽

Author(s):

Keyword(s):

Rheumatoid Arthritis ◽

Lymphoblastic Leukemia ◽

Precursor Cell ◽

Assessment Report ◽

Psoriasis Arthritis ◽

European Public ◽

European Public Assessment Report ◽

Arthritis Rheumatoid

Download Full-text

Human medicines European public assessment report (EPAR): Ilaris, canakinumab, Cryopyrin-Associated Periodic Syndromes,Arthritis, Juvenile Rheumatoid,Arthritis, Gouty, Date of authorisation: 23/10/2009, Revision: 23, Status: Authorised

Case Medical Research ◽

10.31525/cmr-ab02b0 ◽

2019 ◽

Author(s):

Keyword(s):

Rheumatoid Arthritis ◽

Juvenile Rheumatoid Arthritis ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text